Allopurinol
Allopurinol is a xanthine oxidase inhibitor used to reduce elevated uric acid levels in the blood and prevent complications associated with gout and certain types of kidney stones. It works by inhibiting the enzyme responsible for converting purines into uric acid, thereby reducing uric acid production and helping prevent the formation of urate crystals. Allopurinol is also used to manage hyperuricaemia associated with certain cancer treatments, where rapid cell breakdown can increase uric acid levels. It is available as an oral tablet, with dosage adjusted according to the patient’s uric acid levels, kidney function, and clinical response. Common adverse effects include gastrointestinal discomfort and skin rash; rare but potentially life-threatening severe skin reactions can occur. Patients should seek immediate medical attention if a rash develops, and adequate hydration and regular monitoring are important during treatment.
Allopurinol was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Allopurinol, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Allopurinol from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Allopurinol, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
